Technological advances are opening up new drug development opportunities for rare diseases.

Sustainably Industrial: How the Industry is Practicing – And Delivering – Sustainability

The material composition of consumables – whether plastic or glass – impacts their carbon footprints. But which is more efficient?

How a LEGO biomanufacturing facility brought out the inner child in attendees at an industry trade show.

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.

EFPIA signs joint declaration championing open trade in the EU.

We dive into the archive of 2018 for insight and inspiration – this time with Bruno Sepodes

Why cell and gene therapy manufacturing has a lot to learn from the automotive sector.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.